| Q34079353 | A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects |
| Q37435886 | Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease |
| Q29977753 | Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling |
| Q24599108 | Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease |
| Q42096489 | Interactions between cellular proteins and morphologically different nanoscale aggregates of small molecules. |
| Q33303421 | Molecules that target beta-amyloid |
| Q33218208 | Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta |
| Q34124260 | Peptides for therapy and diagnosis of Alzheimer's disease |
| Q50199459 | Use of Peptides for the Management of Alzheimer's Disease: Diagnosis and Inhibition |